Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Vitex doniana methanolic leaf extract is a research-grade natural product derived from the leaves of *Vitex doniana* Sweet (commonly known as black plum), a medicinal plant indigenous to Africa. This complex extract is primarily investigated in preclinical research for its diverse pharmacological properties, including antidiabetic, antioxidant, hepatoprotective, anti-inflammatory, and antimalarial activities. In oncology research, the methanolic extract has been evaluated for its cytotoxic and antiproliferative effects against cervical cancer (HeLa) cells. Mechanistically, the extract and its bioactive constituents—which include flavonoids, tannins, saponins, and phytosterols like γ-sitosterol—modulate the expression of key cancer-associated genes. Specifically, it has been shown to downregulate the androgen receptor (AR) and the anti-apoptotic gene B-cell lymphoma 2 (BCL-2), while influencing the activity of caspase-3, cyclin-dependent kinase 1 (CDK1), and tumor protein P53. Despite its traditional use in herbal medicine, it is not currently an approved pharmaceutical drug and remains in the early stages of scientific validation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on vitex doniana methanolic leaf extract.